Neuropace, Inc. NPCE Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price?
- Neuropace, Inc. (NPCE) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price of $7.2 in Q1 2026.
- How has Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price changed year-over-year?
- Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price increased by 10.1% year-over-year, from $6.54 to $7.2.
- What is the long-term trend for Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price has grown at a 28.4% compound annual growth rate (CAGR), from $2.61 to $7.09.